These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 25666511)

  • 21. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
    J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?
    Chiron C; Helias M; Kaminska A; Laroche C; de Toffol B; Dulac O; Nabbout R; An I
    Epilepsia; 2018 Sep; 59(9):1705-1717. PubMed ID: 30132836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.
    Pernici CD; Mensah JA; Dahle EJ; Johnson KJ; Handy L; Buxton L; Smith MD; West PJ; Metcalf CS; Wilcox KS
    Epilepsia; 2021 Jul; 62(7):1665-1676. PubMed ID: 34002394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and comorbidities of SCN1A-related seizure disorders.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.
    Jullien V; Chhun S; Rey E; Dulac O; Tod M; Chiron C; Pons G
    Clin Pharmacokinet; 2015 May; 54(5):527-36. PubMed ID: 25503589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination Therapy.
    Peigné S; Chhun S; Tod M; Rey E; Rodrigues C; Chiron C; Pons G; Jullien V
    Clin Pharmacokinet; 2018 Jun; 57(6):739-748. PubMed ID: 28819726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis.
    Elliott J; McCoy B; Clifford T; Wells GA; Coyle D
    Pharmacoeconomics; 2018 Oct; 36(10):1253-1261. PubMed ID: 29761351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stiripentol: A Review in Dravet Syndrome.
    Frampton JE
    Drugs; 2019 Nov; 79(16):1785-1796. PubMed ID: 31617141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-center, retrospective analysis of genotype-phenotype correlations in children with Dravet syndrome.
    Gertler TS; Calhoun J; Laux L
    Seizure; 2020 Feb; 75():1-6. PubMed ID: 31864146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).
    Plosker GL
    CNS Drugs; 2012 Nov; 26(11):993-1001. PubMed ID: 23018548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dravet syndrome--considerable delay in making the diagnosis.
    Bremer A; Lossius MI; Nakken KO
    Acta Neurol Scand; 2012 May; 125(5):359-62. PubMed ID: 22050316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two mild cases of Dravet syndrome with truncating mutation of SCN1A.
    Takaori T; Kumakura A; Ishii A; Hirose S; Hata D
    Brain Dev; 2017 Jan; 39(1):72-74. PubMed ID: 27544716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
    Jogamoto T; Yamamoto Y; Fukuda M; Suzuki Y; Imai K; Takahashi Y; Inoue Y; Ohtsuka Y
    Epilepsy Res; 2017 Feb; 130():7-12. PubMed ID: 28081475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stiripentol for the treatment of seizures associated with Dravet syndrome.
    Chiron C
    Expert Rev Neurother; 2019 Apr; 19(4):301-310. PubMed ID: 30900478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dravet syndrome: Treatment options and management of prolonged seizures.
    Cross JH; Caraballo RH; Nabbout R; Vigevano F; Guerrini R; Lagae L
    Epilepsia; 2019 Dec; 60 Suppl 3():S39-S48. PubMed ID: 31904119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
    Bayat A; Hjalgrim H; Møller RS
    Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Stiripentol and the Clinical Outcome in Dravet Syndrome.
    Yıldız EP; Ozkan MU; Uzunhan TA; Bektaş G; Tatlı B; Aydınlı N; Çalışkan M; Özmen M
    J Child Neurol; 2019 Jan; 34(1):33-37. PubMed ID: 30362398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myoclonic Absence Seizures in Dravet Syndrome.
    Myers KA; Scheffer IE
    Pediatr Neurol; 2017 May; 70():67-69. PubMed ID: 28233668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.